Dubai Medical University (DMU)-College of Pharmacy took part in the ISH-ECS 2026 conference, held October 22–25, 2026. Two DMU faculty members served as session chairpersons, joining international experts in hypertension and cardiovascular science.

Dr. Bassam Atallah, Associate Dean for Clinical Affairs at DMU-College of Pharmacy, chaired the session “What Is New with the Renin-Angiotensin System?” The session covered new findings on the renin-angiotensin system (RAS), including its protective counter-regulatory pathways and the tissue-specific mechanisms that lead to organ damage. Speakers also discussed what these findings mean for RAS inhibition in clinical practice today.

Dr. Ahmad El Ouweini, Assistant Professor of Pharmacy Practice and Interim Program Director of the Master of Clinical Pharmacy Program at DMU, chaired the session “New Preclinical Drug Developments for Hypertension and HMOD (Hypertension-Mediated Organ Damage).” The session took place on Saturday, October 24, 2026, with speakers Prof. Jan Danser (Professor of Pharmacology, Rotterdam), Prof. Masaki Mogi (Ehime University, Japan) and Prof. Sebastien Rubin (University of Bordeaux, France). It included the following presentations:

• The Next Generation of Preclinical Targets: Beyond Classic Blockade
• Targeting Renal and Vascular Remodeling in HMOD
• New Therapeutic Opportunities Through Transcriptomic and Proteomic Analysis of the Kidney Renin-Angiotensin System

A panel discussion with the speakers and attendees followed. It looked at how early-stage research could lead to new treatments that protect the kidneys, blood vessels and other organs in patients with hypertension.